Protein Folding Interdiction Strategy for Therapeutic Drug Development in Viral Diseases: Ebola VP40 and Influenza A M1

In a recent paper, we proposed the folding interdiction target region (FITR) strategy for therapeutic drug design in SARS-CoV-2. This paper expands the application of the FITR strategy by proposing therapeutic drug design approaches against Ebola virus disease and influenza A. We predict target regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergasa-Caceres, Fernando, Rabitz, Herschel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998936/
https://www.ncbi.nlm.nih.gov/pubmed/35409264
http://dx.doi.org/10.3390/ijms23073906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998936/
https://www.ncbi.nlm.nih.gov/pubmed/35409264
http://dx.doi.org/10.3390/ijms23073906

Ejemplares similares